UNSPSC 85893520: High dose rate (hdr) brachytherapy of pelvic region using californium 252 (cf-252)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of pelvic region using californium 252 (cf-252). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DW169CZ

UNSPSC 85893520 High dose rate (hdr) brachytherapy of pelvic region using californium 252 (cf-252) is a Commodity code that shows little relevant recent activity in state and local procurement. The single recent opportunity posted under this code—Santa Clara County Health System's July 2026 solicitation RFSQHHSFY270052—is plainly unrelated to the code's nominal scope; the notice solicits temporary health professional staffing services across thirteen ancillary clinical categories including audiology, radiology, respiratory care, and therapy services, with no mention of brachytherapy, radiation oncology, or cf-252 applications. This appears to be a classification mismatch rather than an instance of the therapeutic procedure the code describes.

The mismatch suggests either that the issuing body tagged the opportunity incorrectly or that the code itself is not commonly used in state and local procurement workflows for the specialized oncology service it nominally covers. Without additional opportunities demonstrating actual brachytherapy procurement under this code, no reliable signal emerges regarding the kinds of health systems issuing such work, geographic concentration, or current market activity. Business development professionals should verify whether this code aligns with their service offerings before pursuing opportunities and should confirm the correct UNSPSC family for radiation oncology staffing or equipment leasing if that is the intended scope.